Drug-Eluting Balloon Catheters Market size to surpass around USD 1.1 billion by 2031 |BD Interventional, Biotronik AG, Eurocor GmbH

The global Drug-Eluting Balloon Catheters Market was valued at US$ 400 million in 2021 and it is anticipated to grow up to US$ 1.1 billion by 2031, at a CAGR of 10.7% during the forecast period.

Get Access to A Free Sample Copy of Our Latest Report - https://www.globalinsightservices.com/request-sample/GIS24323

A drug-eluting balloon is a non-stent technology in which the vessel wall processes the effective homogeneous delivery of anti-proliferative drugs via an inflated balloon. Healthcare infrastructure has undergone significant changes in the last decade as technology has proliferated and healthcare research has expanded significantly. Rising obesity, an ageing population, and an increase in the prevalence of coronary artery disease are some of the factors driving demand for drug-eluting balloon catheters. When stents are used in conjunction with a balloon catheter, they are referred to as balloon expandable stents, as opposed to self-expandable stents, which are typically made of nitinol alloy

Market Drivers and Trends

The increasing prevalence of coronary artery disease among people all over the world is the primary driver of the industry's growth. For example, according to the World Health Organization, approximately 3.8 million men and 4.4 million women will die from coronary heart disease. Furthermore, the number of deaths between the ages of 15 and 59 is approximately 1332 million, and the number of deaths over the age of 60 is approximately 5825 million. Furthermore, according to the Centers for Disease Control and Prevention, coronary heart disease will be the most common type of heart disease in upcoming years, killing 382,820 people globally.

View Detailed Report Description - https://www.globalinsightservices.com/reports/drug-eluting-balloon-catheters-market

Furthermore, the industry's growth will be driven by increasing prevalence of diabetes. According to the World Health Organization's October 2018 report, diabetes is responsible for approximately 1.6 million deaths worldwide. According to the Centers for Disease Control and Prevention, diabetes has affected 537 million adults (20-79 years) worldwide in 2021, accounting for one in every ten people. China has the most diabetics in the world, with approximately 141 million people suffering from the disease. Diabetes is expected to affect approximately 174 million people in China by 2045. These factors are expected to drive the growth of the global Drug-Eluting Balloon Catheters Market.

Major Players in the Global Drug-Eluting Balloon Catheters Market

The key players studied in the global Drug-Eluting Balloon Catheters Market are B. Braun Melsungen AG, Medtronic, BD Interventional, Biotronik AG, Eurocor GmbH, MedAlliance, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, iVascular S.L.U, and Cook Medical among others.

Get a customized scope to match your need, ask an expert -
https://www.globalinsightservices.com/request-customization/GIS24323

COVID-19 Impact

The COVID-19 pandemic and lockdown in various countries around the world has had a negative impact on businesses in all sectors. The COVID-19 pandemic has impacted the entire healthcare supply chain, owing to strict lockdown in several regions. Similarly, because of the delayed peripheral, interventional, and cardiovascular surgical procedures caused by the COVID-19 pandemic, the drug-eluting balloon catheters industry suffered greatly. Many countries prioritized the treatment of coronavirus patients in order to keep the system from becoming overburdened by the high case count. All non-emergency procedures, including catheterization, were also postponed in order to redirect resources to pandemic patient treatment and care.

However, demand for drug-eluting balloon catheters is expected to skyrocket in the post-pandemic era. Despite the fact that the pandemic caused a significant drop in sales, the market has recovered the losses in the coming years as research accelerates.

Global Drug-Eluting Balloon Catheters Market Segmentation

By Product

Coronary Artery Disease
Peripheral Vascular Disease

By End-User

Hospitals and Clinics
Ambulatory surgical centers
Catheterization Laboratories

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS24323
With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.